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Cardiac inﬂammatory myoﬁbroblastic tumor (IMT) is a rare entity and is associated with distinct clinical, pathological and
molecular features. The clinical behavior, natural history, biological potential, management and prognosis of such tumors are
unclear.Wepresentherewithanadolescentgirlwhopresentedwithsimilarentityinvolvingthejunctionoftherightatriumandthe
inferior vena cava (IVC) in association with thrombocytosis and IVC thrombosis leading to obstruction of blood ﬂow. Diagnostic
tools included imaging and immuno-histopathology studies. Surgical management included resection of the tumor and thrombo-
embolectomy of the IVC under cardiopulmonary bypass. This case is unique due to association of complete obstruction of IVC
caused by the strategic location of the tumor, thrombosis of vena cava and association of thrombocytosis. These features have not
been reported yet in relation to the cardiac IMT. This report will help in better understanding and management of similar cases
in terms of planning cannulation of femoral veins or application of total hypothermic circulatory arrest during cardiopulmonary
bypass and prompt us to look for recurrence or metastasis during follow up using echocardiography and laboratory investigations.
The possibility of IMT should be kept in the diﬀerential diagnosis of cardiac tumors especially in children and adolescents.
1.Introduction
Primary cardiac tumors are exceedingly rare in children
and adolescents with a reported overall prevalence of
0.08% [1]. Majority of such tumors are benign which
include rhabdomyoma, ﬁbroma, myxoma or, teratoma.
However, recently, Inﬂammatory Myoﬁbroblastic Tumor
(IMT) involving cardiac structures has emerged as a dis-
tinct entity with characteristic clinical, pathological, and
molecular features such as a predilection for the visceral
soft tissues with a tendency for local recurrence, fasciitis-
like compact spindle cell and hypocellular ﬁbrous pattern,
and chromosomal translocation leading to activation of the
ALK tyrosine kinase in almost 50% of the cases [1]. There
are only few reports published describing IMT in patients
between 4 months to 17 years of age with cardiac tissue
involvement [2–7]. We are reporting herewith an adolescent
girl who presented with an obstructive mass (IMT) within
the right atrium-inferior venacava junction causing visceral
congestion, thrombosis of the inferior venacava (IVC), and
thrombocytosis, who underwent urgent surgical interven-
tion. These clinical features are not previously reported
for cardiac IMTs. Due to rarity, behavior, natural history,
management, and prognosis of cardiac IMT are unclear.2 Case Reports in Medicine
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Figure 1: Magnetic resonance scan showing a large tumor mass (T)
at the junction of the right atrium (A) and inferior vena cava in
association with congested liver (L).
Therefore, this paper is not only an addition to the existing
literature but also will help in better understanding and
management of similar cases.
2. Case Presentation
A 14-year-old girl was referred to us for evaluation of a right
atrial mass diagnosed incidentally in the referring hospital
after an appendicectomy.
The patient had pedal oedema and hepatomegaly. The
laboratory tests revealed leucocytosis, thrombocytosis, and
elevated liver enzymes. Two-dimensional echocardiography,
computer tomography including magnetic resonance imag-
ing of the chest showed presence of right-sided contrast-
enhancing mass in the right atrium near IVC junction with a
size of 35×38mm in cross-sectional dimensions (Figure 1).
In addition, there was large thrombus in the IVC extending
below the level of renal veins, causing liver congestion and
ascitis.
In view of the severe obstructive features, possibility
of tumor embolization and unknown nature of the car-
diac mass, an urgent surgical intervention was undertaken
under standard cardiopulmonary bypass. Intraoperative
transoesophageal echocardiography conﬁrmed the location
oftumorwithintherightatrium(Figure2).Thecannulation
of ascending aorta, superior vena cava, and right com-
mon femoral vein was done. Under systemic hypothermia
(25
◦C), aortic cross-clamping and cardioplegic arrest, the
right atriotomy was performed. A large (5×5cm) hard,
grayish, nodular mass was found impacted at the IVC-
right atrial junction circumferentially, and it was diﬃ-
cult to locate the exact point of attachment. The tumor
was excised completely (Figure 3). A 4-minute of deep
hypothermic circulatory arrest (20
◦C) was instituted to
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Figure 2: Transesophageal echocardiogram showing the homoge-
nous echogenic mass (tumor) attached to the posterior wall of
the right atrium (RA) above the tricuspid valve (TV), RV: right
ventricle.
Figure 3: The cut section of excised tumor mass
remove thrombus from the proximal IVC using Fogarty’s
catheter and saline ﬂush. The postoperative course was
uneventful. At 1-year follow-up the patient is asymptomatic
and has no clinical or biochemical features of recur-
rence.
Histopathology of the tumor revealed presence of myoﬁ-
broblasts, fusiform and spindle cells, modest inﬂammatory
inﬁltrates, and myxoid stroma in the background of small
lymphocytes, plasma cells, and eosinophils (Figures 4(a) and
4(b)). The immunostain marker proﬁle showed productivity
for vimentin, smooth muscle actin isoforms, and MyoD, but
negativity for desmin, ALK-1 protein, and S-100 protein
(Figures 4(c) and 4(d)). The constellation of ﬁndings
described above established a diagnosis of IMT.Case Reports in Medicine 3
(a)
(b)
(c)
(d)
Vimentin
Smooth muscle
actin
Figure 4: (a) and (b) Histopathology of tumor showing pro-
liferation of myoﬁbroblasts, inﬂammatory cells, spindle, and
fusiform cells in a myxoid stroma (hematoxylin & eosin,
x100 & x400 magniﬁcations). (c) Immunophenotype—Vimentin
expression in myoﬁbroblastic population (immunoperoxidase,
x200). (d) Immunophenotype—Smooth muscle actin coexpression
(immunoperoxidase, x200)
3. Discussion
Usually, IMT involves lungs, liver, stomach, lymph nodes,
retroperitoneal tissue, and spleen [1]. World Health Organi-
zation’s classiﬁcation has included IMT as tumor of interme-
diatebiologicalpotentialduetotendencyforlocalrecurrence
and small risk of metastasis [1]. Cardiac involvement is very
rare[1–7].Intheavailablepapers,involvedcardiacstructures
were right atrium, right ventricle, tricuspid valve, and inter
ventricular septum [2–7].
There are no speciﬁc signs or symptoms related to
the cardiac IMT’s, as these are related to the location
within the heart. However, these tumors are thought to
elaborate cytokines that may produce constitutional symp-
toms and signs such as fever, anorexia, anemia, hyper
gamma-globulinemia,leukocytoclasticvasculitis,polyarthri-
tis, and thrombocytosis [1, 3]. The pathogenesis of IMT
is thought to be an exaggerated immunologic response
by proliferated spindle cells and primary myoﬁbroblasts
to injury, inﬂammation, or infection [3]. In addition, the
IMT is characterized by expression of vimentin, smooth
muscle actin, and cytokeratins, corresponding to those
of myoﬁbroblasts along with other inﬂammatory mark-
ers [8]. In our patient the Interlukin-6 (IL-6) was also
found to be elevated (17ng/ml). Several authors have
demonstrated production of IL-6 mRNA and protein by
tumor cells, supporting a possible analogous mechanism
in IMT. Interleukin production is thought to be an addi-
tional underlying cause of the systemic symptoms and
complications which may return to normal postoperatively
[1]. Similarly, IL-6 and cytokines may be inﬂammatory
markers of tumor recurrence during postoperative follow-up
[1].
Surgical excision of the tumor has been the mainstay
of the management, though radiotherapy, immunosuppres-
sant, and chemotherapy have been tried as an adjunct to
surgery without additional beneﬁt [8]. In our case, due
to obstruction of IVC caused by tumor and associated
thrombosis, an urgent surgical intervention was warranted.
Moreover, complete removal of thrombus from the supra-
hepatic IVC required cannulation of right common femoral
vein and a brief period of circulatory arrest. Therefore,
a careful observation, planning, and timely surgical man-
agement is the key to the successful outcome in similar
cases.
4. Conclusion
Cardiac IMT’s are potentially benign lesions with favor-
able prognosis and should be considered in the diagnosis
of cardiac tumors in children and adolescents. Surgical
management is currently the preferred treatment approach.
Although, recurrence or metastasis of cardiac IMT has not
been reported yet, the followup of such patients should be
aimed to monitor tumor recurrence which may be heralded
byareturnofclinicalorlaboratoryabnormalities.Therefore,
a physical examination, echocardiography, and blood tests
for inﬂammatory markers, platelets count, and IL-6 levels
are mandatory at regular intervals during long-term follow-
up. In addition, patients should be informed about variable
biological behavior and nature of this entity.
Acknowledgement
The authors thank Mr. Eberhard Vestweber —Wilmes for
photography.
References
[1] B.C.GleasonandJ.L.Hornick,“Inﬂammatorymyoﬁbroblastic
tumours: where are we now?” Journal of Clinical Pathology, vol.
61, no. 4, pp. 428–437, 2008.
[2] P. Stark, J. C. Sandbank, C. Rudnicki, and I. Zahavi, “Inﬂam-
matory pseudotumor of the heart with vasculitis and venous
thrombosis,” Chest, vol. 102, no. 6, pp. 1884–1885, 1992.
[3] L. Li, L. A. Cerilli, and M. R. Wick, “Inﬂammatory pseudotu-
mor (myoﬁbroblastic tumor) of the heart,” Annals of Diagnostic
Pathology, vol. 6, no. 2, pp. 116–121, 2002.
[ 4 ]V .T .D eM o n t p r ´ eville, A. Serraf, H. Aznag, N. Nashashibi,
C. Planch´ e, and E. Dulmet, “Fibroma and inﬂammatory
myoﬁbroblastic tumor of the heart,” Annals of Diagnostic
Pathology, vol. 5, no. 6, pp. 335–342, 2001.
[5] K. A. Murdison, S. Septimus, R. E. Garola, and C. Pizarro,
“Intracardiac inﬂammatory myoﬁbroblastic tumor: a unique
presentation,” EuropeanJournalofCardio-ThoracicSurgery,vol.
31, no. 4, pp. 750–752, 2007.
[6] M. S. Anvari, A. Soleimani, A. Abbasi et al., “Inﬂammatory
myoﬁbroblastic tumor of the right ventricle causing tricuspid
valve regurgitation,” Texas Heart Institute Journal,v o l .3 6 ,n o .2 ,
pp. 164–167, 2009.
[7] P. Vaideeswar, A. M. Patwardhan, and P. A. Sathe, “Cardiac
valvular inﬂammatory pseudotumor,” Journal of Cardiothoracic
Surgery, vol. 3, no. 1, article 53, 2008.4 Case Reports in Medicine
[8] S. V. S. Attili, C. R. Chandra, D. K. Hemant, P. P. Bapsy, C.
RamaRao, and G. Anupama, “Retroperitoneal inﬂammatory
myoﬁbroblastic tumor,” WorldJournalofSurgicalOncology, vol.
3, article 66, 2005.